You are here:Home1/Animal Models And It’s Screening Platforms
Animal Models And It’s Screening Platforms
Infection: Customizable Immunized Mouse Models and its Screening Platforms
Helping to advance COVID-19 vaccines & therapeutics and adjuvants
Immunized mouse model with Spike1 for long and short-term projects along with its screening platforms such as ELIPSPOT (Th1 and Th2, B-cell responses), ELISA (IgG, IgM) and Neutralizing Abs, Cytokine and Chemokine analysis with MCYTMG-70K-PX32, In-vivo imaging for biodistribution, andtime-course Fluorescent microscopy imaging.
-Gene Therapy Applications -Drug Screening for Sepsis -Testing Therapeutic Agents for – Inflammatory and Immunological – Diseases
-Characterization of the Cellular Profile by Recruited Granulocytes
-Biomarker Level Detection in the Lung and BAL
-Non-invasive Pulmonary inflammation and Acute Lung Injury using a Mesh-Nebulizer System. -Bacterial Lung Infection
Our Models for Immunotherapy Drug and Therapeutic Development
In tumor-bearing mice, the effect of single-agent anti-PD-1 compared with control antibody on tumor growth and survival.
Morpheus Biolabs provides in vivo study platforms and ex vivo analysis services for immunotherapy drug and therapeutic development. Please inquire about our different preclinical in vivo models for immuno-oncology, including syngeneic tumor models for testing the efficacy and profiling of combination therapies. In tumor-bearing mice, the effect of single-agent anti-PD-1 compared with control antibody on tumor growth and survival.